Pressor therapy in acute ischaemic stroke: an updated systematic review
- PMID: 35647316
- PMCID: PMC9134777
- DOI: 10.1177/23969873221078136
Pressor therapy in acute ischaemic stroke: an updated systematic review
Erratum in
-
ERRATUM to Pressor therapy in acute ischaemic stroke: An updated systematic review.Eur Stroke J. 2023 Mar;8(1):409. doi: 10.1177/23969873221133920. Epub 2022 Oct 26. Eur Stroke J. 2023. PMID: 37021201 Free PMC article.
Abstract
Background: Low blood pressure (BP) in acute ischaemic stroke (AIS) is associated with poor functional outcome, death, or severe disability. Increasing BP might benefit patients with post-stroke hypotension including those with potentially salvageable ischaemic penumbra. This updated systematic review considers the present evidence regarding the use of vasopressors in AIS.
Methods: We searched the Cochrane Database of Systematic Reviews, MEDLINE, EMBASE and trial databases using a structured search strategy. We examined reference lists of relevant publications for additional studies examining BP elevation in AIS.
Results: We included 27 studies involving 1886 patients. Nine studies assessed increasing BP during acute reperfusion therapy (intravenous thrombolysis, mechanical thrombectomy, intra-arterial thrombolysis or combined). Eighteen studies tested BP elevation alone. Phenylephrine was the most commonly used agent to increase BP (n = 16 studies), followed by norepinephrine (n = 6), epinephrine (n = 3) and dopamine (n = 2). Because of small patient numbers and study heterogeneity, a meta-analysis was not possible. Overall, BP elevation was feasible in patients with fluctuating or worsening neurological symptoms, large vessel occlusion with labile BP, sustained post-stroke hypotension and ineligible for intravenous thrombolysis or after acute reperfusion therapy. The effects on functional outcomes were largely unknown and close monitoring is advised if such intervention is undertaken.
Conclusion: Although theoretical arguments support increasing BP to improve cerebral blood flow and sustain the ischaemic penumbra in selected AIS patients, the data are limited and results largely inconclusive. Large, randomised controlled trials are needed to identify the optimal BP target, agent, duration of treatment and effects on clinical outcomes.
Keywords: acute; blood pressure; elevation; induced hypertension; ischaemic; stroke; vasopressor.
© European Stroke Organisation 2022.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Endovascular thrombectomy and intra-arterial interventions for acute ischaemic stroke.Cochrane Database Syst Rev. 2021 Jun 14;6(6):CD007574. doi: 10.1002/14651858.CD007574.pub3. Cochrane Database Syst Rev. 2021. PMID: 34125952 Free PMC article.
-
Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.J Thromb Thrombolysis. 2022 Aug;54(2):339-349. doi: 10.1007/s11239-022-02670-0. Epub 2022 Jun 14. J Thromb Thrombolysis. 2022. PMID: 35699873
-
Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.Health Technol Assess. 2009 Jan;13(9):iii, ix-xi, 1-73. doi: 10.3310/hta13090. Health Technol Assess. 2009. PMID: 19208305 Clinical Trial.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.Int J Stroke. 2015 Jul;10(5):778-88. doi: 10.1111/ijs.12486. Epub 2015 Apr 2. Int J Stroke. 2015. PMID: 25832995 Clinical Trial.
Cited by
-
Chronic hypertension alters the relationship between collateral blood flow cortical cerebral blood flow, and brain tissue oxygenation.J Cereb Blood Flow Metab. 2024 Nov;44(11):1227-1237. doi: 10.1177/0271678X241258569. Epub 2024 May 28. J Cereb Blood Flow Metab. 2024. PMID: 38806143 Free PMC article.
-
Impaired Peripheral Vascular Function Following Ischemic Stroke in Mice: Potential Insights into Blood Pressure Variations in the Post-Stroke Patient.Pathophysiology. 2024 Sep 5;31(3):488-501. doi: 10.3390/pathophysiology31030036. Pathophysiology. 2024. PMID: 39311310 Free PMC article.
-
Emergent endovascular treatment versus medical treatment for acute large vessel occlusions with nondisabling symptoms.Interv Neuroradiol. 2024 Dec;30(6):827-832. doi: 10.1177/15910199241286551. Epub 2024 Oct 3. Interv Neuroradiol. 2024. PMID: 39360421 Free PMC article.
-
Neuroimaging-Based Responses to Blood Pressure Augmentation in Acute Ischaemic Stroke: A Systematic Review.Biomed Hub. 2025 Jan 2;10(1):50-56. doi: 10.1159/000543341. eCollection 2025 Jan-Dec. Biomed Hub. 2025. PMID: 40041759 Free PMC article. Review.
References
-
- CAST . Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) collaborative group. Lancet 1997; 349: 1641–1649. 1997/06/07. - PubMed
-
- The International Stroke Trial (IST) . A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International stroke trial collaborative group. Lancet 1997; 349: 1569–1581. 1997/05/31. - PubMed
-
- Mulder M, Ergezen S, Lingsma HF, et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in mr clean (multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands). Stroke 2017; 48: 1869–1876. 2017/04/23. DOI: 10.1161/strokeaha.116.016225. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources